Regulatory Disclosures. In the event that any Credit Party receives a subpoena, notice of requirement to disclose or any request to disclose any information about any Purchaser from any Governmental Authority, or any applicable Law or Order (other than Excluded Laws) requires any Credit Party to disclose any information about any Purchaser (each is a “Regulatory Disclosure Requirement”), such Credit Party shall, to the extent permissible, prior to disclosing such information, promptly notify the Holders of such Regulatory Disclosure Requirement and permit the Holders and their counsel to seek a protective order or otherwise restrict the disclosure of such information. Further, each Credit Party shall cooperate in good faith with the Holders in their efforts to obtain a protective order or take such other action as the Holders deem necessary, and if a protective order or other remedy is not obtained despite the Holders’ efforts, the Credit Parties shall disclose only that portion of the information that the Credit Parties are legally required to disclose and will make reasonable efforts to obtain reliable assurance that confidential treatment will be afforded that information. Notwithstanding the foregoing, the Company may make disclosures in accordance with its obligations to report the transactions contemplated hereby under the policies of the CSE and under applicable Canadian Securities Laws, including disclosure of the names of the Holders, the amount purchased, and certain other required information.
Regulatory Disclosures. The Subsidiary hereby acknowledges and agrees to the following:
Regulatory Disclosures. 8.1 The Parties acknowledge and agree that there is (a) an unpredictable regulatory environment in the area of cannabis law and that existing or new laws, interpretations of law, or enforcement policies may adversely impact the Parties’ business and (b) notwithstanding the favorable treatment under the laws of certain jurisdictions, Cannabis is a prohibited controlled substance under the laws of many jurisdictions.
Regulatory Disclosures. The Parties acknowledge that a Party may at some point in time be obligated to file a copy of this Agreement with applicable governmental authorities having regulatory authority over such Party securities or the exchange thereof. In such case, such Party shall be entitled to make such a required filing, provided that it requests confidential treatment of the commercial terms and sensitive technical terms hereof to the extent such confidential treatment is reasonably available to such Party and permitted by such governmental authority. In the event of any such filing, such Party will provide the other Party with a copy of the Agreement marked to show provisions for which the filing Party intends to seek confidential treatment and shall reasonably consider and incorporate the other Party’s comments thereon to the extent consistent with the legal requirements governing redaction of information from material agreements that must be publicly filed. The other Party will as promptly as practical provide any such comments. The other Party recognizes that applicable Laws, including regulations promulgated by applicable governmental authorities, to which the filing Party is and may become subject to may require the filing Party to publicly disclose certain terms of this Agreement that the other Party may prefer not be disclosed, and that the filing Party is entitled hereunder to make such required disclosures to the minimum extent necessary to comply with such Laws.
Regulatory Disclosures. This section of the booklet includes information that you may find helpful regarding your account, and certain disclosures required by government regulation. Information in this section is not part of our Agreement regarding your accounts.
Regulatory Disclosures. Any non‑disclosure provision in this General Release does not prohibit or restrict me (or my attorney) from responding to any inquiry about this General Release or its underlying facts and circumstances by the Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), any other regulatory organization or any governmental entity.
Regulatory Disclosures. Purchaser understands and agrees that the Company shall and may make such public and regulatory filings and notices, disclosing the transactions contemplated hereby, in the manner and time required by the Commission and by state regulators, including the filing of this Agreement. Purchaser agrees to promptly review and comment on any proposed press release which the Company furnishes to Purchaser per Section 6(j).
Regulatory Disclosures. Each party agrees that it shall not be deemed a breach of this Agreement for any other party to disclose the terms and conditions of this Agreement in any required regulatory filing with the Securities & Exchange Commission, a national stock exchange or the NASDAQ, which the other party, in good faith, determines is required, provided the other party seeks confidential treatment of the material financial terms and conditions of this Agreement.
Regulatory Disclosures. 1. EBH has its registered office at Sofia 0000, Xxxxxxxx, Xxxxxxxxxxx Xxxxxxxx, 00 Xxxx Xxxxxxx Xxx., xx. 2, office 8 and is authorised and regulated by the Financial Supervision Commission – the regulatory authority of the Republic of Bulgaria, with the address 0000 Xxxxx, 00, Xxxxxxxxxx Xxx., tel.: 00 00 00 000, fax: 00 000 00 00, e-mail: xx_xxx@xxx.xx. EBH holds the license № RG-03-197/01.07.2020, issued by the Financial Supervision Commission, to conduct business in the European Union and the European Economic Area.
2. Services for which EBH is licensed:
2.1. acceptance and transmission of orders in relation to one or more financial instruments;
2.2. executing orders on behalf of clients;
2.3. trading with financial instruments on the Company’s account;
2.4. portfolio management;
2.5. investment advice;
2.6. accepting issues of financial instruments and / or offering financial instruments subject to an unconditional and irrevocable obligation to subscribe / acquire financial instruments for the Company’s account;
2.7. initial offering of financial instruments without an unconditional and irrevocable obligation to acquire financial instruments for Company’s account.
3. Additional services for which EBH is licensed:
3.1. to store and administer financial instruments at the expense of clients, including custodian and related services such as cash and collateral management, except for centralised securities accounts under Section A, point 2 of the Annex to Regulation (EU) № 909/2014;
3.2. to provide loans to investors to make transactions with one or more financial instruments pro- vided that the intermediary providing the loan participates in the transaction;
3.3. to provide business advice on capital structure, industrial strategy and related issues, as well as advice and services related to business transformation and acquisition;
3.4. to provide services related to a foreign means of payment, insofar as they relate to the invest- ment services provided;
3.5. to provide investment research and financial analysis or other forms of general recommenda- tion relating to transactions in financial instruments;
3.6. to provide financial instrument issuing services;
3.7. to provide investment services and activities under para. 2 and items 1 - 6 in connection with the underlying instruments of derivative financial instruments under Art. 4, items 5, 6, 7 and 10 of the Markets in Financial Instruments Act (MFIA), when related to the provision of investment and an...
Regulatory Disclosures. The Receiving Party may disclose the Disclosing Party’s Confidential Information (without the Disclosing Party’s prior written permission) if such disclosure is made to officers, employees, or advisors of any Regulatory Authorities for the purpose of performing Product Development Activities, submitting Regulatory Filings for the Program, or obtaining Marketing Approval for the Product. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE DERMAVANT SCIENCES LTD. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO DERMAVANT SCIENCES LTD. IF PUBLICLY DISCLOSED. Notwithstanding the foregoing, the Receiving Party shall be responsible for any breach of this ARTICLE VI (Confidential Information) by any of the Third Parties described in this Section 6.3(a) (Permitted Disclosures) to which it discloses Confidential Information (as if such Third Party was bound by the terms of this ARTICLE VI (Confidential Information)), and shall take all reasonably necessary measures to restrain such Third Parties from unauthorized disclosure or use of the Confidential Information.
